Company profile

Concert AI

Concert AI has raised a total of $300 million across two funding rounds a $150 million Series B in January 2020 led by Declaration Partners, Maverick Ventures, AllianceBernstein, and SymphonyAI, and a $150 million Series C in March 2022 led by Sixth Street - reaching a $1.9 billion valuation. Founded in 2018 and headquartered in Boston, Massachusetts, Concert AI leverages artificial intelligence to deliver oncology data insights, clinical trial matching, and research optimization for biopharma and healthcare organizations, advancing precision oncology and improving patient outcomes worldwide.

Back to profiles

Quick facts

Total funding: $300 million
Valuation: $1.9 billion
Founded: 2018
Headquarters: Boston, Massachusetts, Concert AI leverages artificial intelligence to deliver oncology data insights

Notable investors

Declaration Partners
Maverick Ventures
AllianceBernstein
SymphonyAI

Reach buyers like Concert AI on TexAu

TexAu helps go-to-market teams find, enrich, and reach companies that match this profile. Pick the path that fits how you work.

Find companies like Concert AI
Build a list by industry, headcount, funding stage, or technographics. Get verified emails and direct dials.
Start a free workspace
Enrich your CRM with company data
Push funding, headcount, hiring signals, and tech stack into HubSpot, Salesforce, or a spreadsheet. Waterfall enrichment.
See how the waterfall works
Run it on a schedule
Refresh the list weekly, score new accounts as they land, and push the ones that fit to Smartlead, Instantly, Lemlist, HeyReach, or Apollo Sequences.
See how schedulers work

Reach buyers like Concert AI.

The 14-day trial ships every feature, no card required.

Start free →